Your browser doesn't support javascript.
loading
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.
Jung, Ki Sun; Kim, Yoo-Jin; Kim, Yeo-Kyeoung; Park, Sung Kyu; Kim, Hoon Gu; Kim, Soo Jeong; Park, Jinny; Choi, Chul Won; Do, Young Rok; Kim, Inho; Park, Seonyang; Mun, Yeung-Chul; Jeong, Seong Hyun; Kim, Min-Kyoung; Yi, Hyeon Gyu; Chang, Myung Hee; Kim, Su Youn; Lee, Je-Hwan; Jang, Jun Ho.
Afiliação
  • Jung KS; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medici
  • Kim YJ; Acute Leukemia Center, Seoul St Mary's Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Kim YK; Department of Hematology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea.
  • Park SK; Department of Internal Medicine, Soonchunhyang University Hospital, Bucheon, Korea.
  • Kim HG; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongnam Regional Cancer Center, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea.
  • Kim SJ; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Park J; Department of Internal Medicine, Gachon University Gil Hospital, Incheon, Korea.
  • Choi CW; Division of Oncology and Hematology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea.
  • Do YR; Division of Hematology-Oncology, School of Medicine, Keimyung University, Daegu, Korea.
  • Kim I; Department of Internal Medicine, Seoul National University, Seoul, Korea.
  • Park S; Department of Internal Medicine, Seoul National University, Seoul, Korea.
  • Mun YC; Department of Hematology and Oncology, School of Medicine, Ewha Womans University, Seoul, Korea.
  • Jeong SH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
  • Kim MK; Division of Oncology-Hematology, Department of Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • Yi HG; Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
  • Chang MH; Department of Hematology-Oncology, National Health Insurance Service Ilsan Hospital, Ilsan, Korea.
  • Kim SY; Medical Affairs, Janssen Korea, Seoul, Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address: jhlee3@amc.seoul.kr.
  • Jang JH; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address: junhojang@skku.edu.
Clin Lymphoma Myeloma Leuk ; 19(10): 656-664, 2019 10.
Article em En | MEDLINE | ID: mdl-31375393
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Avaliação de Resultados em Cuidados de Saúde / Medição de Risco / Decitabina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Avaliação de Resultados em Cuidados de Saúde / Medição de Risco / Decitabina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article